Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 25.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 109,200 shares of the real estate investment trust's stock after purchasing an additional 22,300 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Healthpeak Properties were worth $2,213,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the company. State Street Corp acquired a new position in Healthpeak Properties in the third quarter valued at approximately $1,093,576,000. Geode Capital Management LLC acquired a new position in Healthpeak Properties in the third quarter valued at approximately $403,898,000. Principal Financial Group Inc. boosted its stake in Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after acquiring an additional 17,314,572 shares during the period. Charles Schwab Investment Management Inc. acquired a new position in Healthpeak Properties in the third quarter valued at approximately $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Healthpeak Properties in the third quarter valued at approximately $175,697,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have commented on the company. Robert W. Baird decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Wedbush decreased their target price on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, February 14th. Royal Bank of Canada lifted their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. Wells Fargo & Company cut their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 10th. Finally, Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus target price of $24.00.
View Our Latest Research Report on Healthpeak Properties
Shares of NYSE:DOC opened at $20.00 on Thursday. Healthpeak Properties, Inc. has a 12 month low of $16.01 and a 12 month high of $23.26. The stock has a market cap of $13.99 billion, a price-to-earnings ratio of 57.13, a PEG ratio of 2.17 and a beta of 1.15. The stock's 50 day moving average price is $20.17 and its 200 day moving average price is $21.37. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35.
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a dividend of $0.305 per share. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.22 annualized dividend and a yield of 6.10%. Healthpeak Properties's payout ratio is presently 348.57%.
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.